Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Anglaret

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Leukemia|August 1, 1992
Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderlyE Archimbaud, B Anglaret, X Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropeniaJ Y Blay, F Chauvin, A Le Cesne, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)N Ketterer, B Coiffier, C Thieblemont, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Leukemia|August 1, 1992
Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderlyE Archimbaud, B Anglaret, X Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropeniaJ Y Blay, F Chauvin, A Le Cesne, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2009
A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study groupI Ray-Coquard, S Dussart, C Goillot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2012
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)N Ketterer, B Coiffier, C Thieblemont, et al.
Pageof 2